2025-10-24 – Press Releases – www.prnewswire.com
BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for the treatment of Hepatitis D Virus…
